Telomerase enzyme inhibition (TEI) and cytolytic therapy in the management of androgen independent osseous metastatic prostate cancer.

Source:http://linkedlifedata.com/resource/pubmed/id/20043297

Prostate 2010 May 1 70 6 616-29

Download in:

View as

General Info

PMID
20043297